An agonist of receptors, adrenergic alpha-2 that is used in veterinary medicine for its analgesic and sedative properties. It is the racemate of dexmedetomidine.
Administered intravenously, dexmedetomidine is indicated for the sedation of initially intubated and mechanically ventilated patients during treatment in intensive care settings, and for the sedation of non-intubated patients prior to and/or during surgery and other procedures. It is also available as a buccally- or sublingually-administered dissolvable film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder.
Gangnam severance hospital, Seoul, Korea, Republic of
Department of Anesthesiology and Pain Medicine and Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Korea, Republic of
Severance Hospital, Seoul, Korea, Republic of
Penn State Hershey Medical Center, Hershey, Pennsylvania, United States
British Columbia Children's Hospital, Vancouver, British Columbia, Canada
Childrens Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.